CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice

Journal of Immunology

Volumn 185, Issue 12, 2010, Pages 7654-7662

  Wang, Jun ^a,b   Zhao, Wenxia ^c   Cheng, Liang ^a,b   Guo, Mingzhou ^d   Li, Dongling ^a   Li, Xiaozhu ^a   Tan, Yi ^a,b   Ma, Suping ^c   Li, Suyun ^c   Yang, Yunsheng ^d   Chen, Lieping ^a,e,f   Wang, Shengdian ^a,b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 LIGAND; GAMMA INTERFERON; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOPATHOLOGY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD137; ANTIGENS, CD14; CARCINOMA, HEPATOCELLULAR; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOLOGIC MEMORY; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MONOCYTES; UP-REGULATION;

EID: 78650635187     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000927     Document Type: Article

References (31)

1. Guidotti, L. G., and F. V. Chisari. 2006. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1:23-61.
2. Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
3. Thimme, R., S. Wieland, C. Steiger, J. Ghrayeb, K. A. Reimann, R. H. Purcell, and F. V. Chisari. 2003. CD8 (+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77:68-76.
4. Maini, M. K., C. Boni, C. K. Lee, J. R. Larrubia, S. Reignat, G. S. Ogg, A. S. King, J. Herberg, R. Gilson, A. Alisa, et al. 2000. The role of virus-specific CD8 (+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191:1269-1280.
5. Boni, C., P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, et al. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81:4215-4225. (Pubitemid 46586915)
6. Das, A., M. Hoare, N. Davies, A. R. Lopes, C. Dunn, P. T. Kennedy, G. Alexander, H. Finney, A. Lawson, F. J. Plunkett, et al. 2008. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205:2111-2124.
7. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3:609-620.
8. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23:23-68.
9. Myers, L. M., and A. T. Vella. 2005. Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation. Trends Immunol. 26:440-446.
10. Halstead, E. S., Y. M. Mueller, J. D. Altman, and P. D. Katsikis. 2002. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat. Immunol. 3:536-541.
11. Tan, J. T., J. K. Whitmire, K. Murali-Krishna, R. Ahmed, J. D. Altman, R. S. Mittler, A. Sette, T. C. Pearson, and C. P. Larsen. 2000. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J. Immunol. 164:2320-2325.
12. Zhu, Y., G. Zhu, L. Luo, A. S. Flies, and L. Chen. 2007. CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype. Blood 109:4882-4889.
13. Melero, I., W. W. Shuford, S. A. Newby, A. Aruffo, J. A. Ledbetter, K. E. Hellström, R. S. Mittler, and L. Chen. 1997. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3:682-685.
14. Chen, Y., H. Wei, R. Sun, Z. Dong, J. Zhang, and Z. Tian. 2007. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 46:706-715.
15. Canbay, A., M. E. Guicciardi, H. Higuchi, A. Feldstein, S. F. Bronk, R. Rydzewski, M. Taniai, and G. J. Gores. 2003. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J. Clin. Invest. 112:152-159.
16. Manning, D. S., and N. H. Afdhal. 2008. Diagnosis and quantitation of fibrosis. Gastroenterology 134:1670-1681.
17. Chisari, F. V., C. A. Pinkert, D. R. Milich, P. Filippi, A. McLachlan, R. D. Palmiter, and R. L. Brinster. 1985. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 230:1157-1160.
18. Chisari, F. V., K. Klopchin, T. Moriyama, C. Pasquinelli, H. A. Dunsford, S. Sell, C. A. Pinkert, R. L. Brinster, and R. D. Palmiter. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156.
19. Schirmbeck, R., J. Wild, and J. Reimann. 1998. Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen. Eur. J. Immunol. 28:4149-4161.
20. Isogawa, M., Y. Furuichi, and F. V. Chisari. 2005. Oscillating CD8 (+) T cell effector functions after antigen recognition in the liver. Immunity 23:53-63.
21. Niu, L., S. Strahotin, B. Hewes, B. Zhang, Y. Zhang, D. Archer, T. Spencer, D. Dillehay, B. Kwon, L. Chen, et al. 2007. Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J. Immunol. 178:4194-4213.
22. Falasca, K., C. Ucciferri, M. Dalessandro, P. Zingariello, P. Mancino, C. Petrarca, E. Pizzigallo, P. Conti, and J. Vecchiet. 2006. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann. Clin. Lab. Sci. 36:144-150.
23. Zylberberg, H., A. C. Rimaniol, S. Pol, A. Masson, D. De Groote, P. Berthelot, J. F. Bach, C. Bréchot, and F. Zavala. 1999. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J. Hepatol. 30:185-191.
24. Choi, I., H. S. Kang, Y. Yang, and K. H. Pyun. 1994. IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin. Exp. Immunol. 95:530-535.
25. Seki, E., S. de Minicis, S. Inokuchi, K. Taura, K. Miyai, N. van Rooijen, R. F. Schwabe, and D. A. Brenner. 2009. CCR2 promotes hepatic fibrosis in mice. Hepatology 50:185-197.
26. Duffield, J. S., S. J. Forbes, C. M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J. P. Iredale. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115:56-65.
27. Ahmad, N., C. R. Gardner, E. J. Yurkow, and D. L. Laskin. 1999. Inhibition of macrophages with gadolinium chloride alters intercellular adhesion molecule-1 expression in the liver during acute endotoxemia in rats. Hepatology 29:728-736.
28. Wirth, S., L. G. Guidotti, K. Ando, H. J. Schlicht, and F. V. Chisari. 1995. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. J. Immunol. 154:2504-2515.
29. Narazaki, H., Y. Zhu, L. Luo, G. Zhu, and L. Chen. 2010. CD137 agonist antibody prevents cancer recurrence: contribution of CD137 on both hematopoietic and nonhematopoietic cells. Blood 115:1941-1948.
30. Gilles, P. N., D. L. Guerrette, R. J. Ulevitch, R. D. Schreiber, and F. V. Chisari. 1992. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma. Hepatology 16:655-663.
31. Sakai, N., T. Wada, K. Furuichi, K. Shimizu, S. Kokubo, A. Hara, J. Yamahana, T. Okumura, K. Matsushima, H. Yokoyama, and S. Kaneko. 2006. MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J. Leukoc. Biol. 79:555-563.